DIS3 and plasma cell myeloma: This observation is not restricted to DIS3 but rather applies to the other ten significantly mutated genes in myeloma patients, KRAS, NRAS, TP53, FAM46C, BRAF, TRAF3, PRDM1, CYLD, RB1 and ACTG1.